Proton Pump Inhibitors and the Risk for Fracture at Specific Sites: Data Mining of the FDA Adverse Event Reporting System

Proton pump inhibitors (PPIs) are widely used to treat gastric acid-related disorders. Concerns have been raised about potential fracture risk, especially at the hip, spine and wrist. However, fracture risk at other bone sites has not been as well studied. We investigated the association between PPI...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Liwei, Li, Mei, Cao, Yuying, Han, Zhengqi, Wang, Xueju, Atkinson, Elizabeth J., Liu, Hongfang, Amin, Shreyasee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514095/
https://www.ncbi.nlm.nih.gov/pubmed/28717153
http://dx.doi.org/10.1038/s41598-017-05552-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514095/
https://www.ncbi.nlm.nih.gov/pubmed/28717153
http://dx.doi.org/10.1038/s41598-017-05552-1

Ejemplares similares